Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
First Opinion
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharma
STAT+

STAT+ Conversations: the revitalization of the antibiotic drug pipeline

  • Ed Silverman

By Ed Silverman July 20, 2021

Reprints

Editor’s note: A recording of the conversation is embedded below.

Every week, STAT+ subscribers get access to exclusive content with biotech, pharma, and health tech leaders. This week, STAT Pharmalot columnist and senior writer Ed Silverman will be joined by John Rex, editor-in-chief at AMR Solutions and chief medical officer at F2G Ltd. They will be discussing the revitalization of the antibiotic drug pipeline, drug development efforts, legislation and model programs to move the ball forward, and of course be taking your questions live.

advertisement

Featured Speakers:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

Biotechs face challenges as the industry’s annual bash returns…
Biotechs face challenges as the industry’s annual bash returns to Boston
Drug used to halt puberty in children may cause…
Drug used to halt puberty in children may cause lasting health problems
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Biotechs face challenges as the industry’s annual bash returns…
Biotechs face challenges as the industry’s annual bash returns to Boston
‘Extraordinary’ survival data for lung cancer patients is seen…
‘Extraordinary’ survival data for lung cancer patients is seen as boost for AstraZeneca drug
Targeted drug greatly slows progression of a brain cancer
Targeted drug greatly slows progression of a brain cancer

Recommended Stories